We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PGNY market cap is 2.45B. The company's latest EPS is USD 0.6429 and P/E is 39.38.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 258.39M | 279.37M | 280.89M | 269.94M | 278.08M |
| Operating Income | 15.01M | 15.18M | 18.19M | 13.8M | 18.52M |
| Net Income | 17.68M | 14.99M | 15.9M | 13.47M | 16.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 229.68M | 344.86M | 500.62M | 786.91M | 1.09B |
| Operating Income | 9.68M | 8.35M | 32.34M | 23.34M | 62.18M |
| Net Income | -8.57M | 46.46M | 65.77M | 30.36M | 62.04M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 649.72M | 681.54M | 726.51M | 756.62M | 794.3M |
| Total Liabilities | 225.32M | 212.04M | 211.12M | 203.19M | 222.7M |
| Total Equity | 424.4M | 469.5M | 515.39M | 553.43M | 571.6M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 150.43M | 253.93M | 358.07M | 542.99M | 756.62M |
| Total Liabilities | 36.16M | 86.98M | 106.24M | 166.02M | 203.19M |
| Total Equity | 114.27M | 166.95M | 251.82M | 376.97M | 553.43M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 20.96M | 96.97M | 151.16M | 188.81M | 25.73M |
| Investing | 16.13M | -42.8M | -107.11M | -200.53M | 19.34M |
| Financing | -1.85M | -3.69M | -6.05M | -11.07M | -27.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.53M | 36.2M | 26.04M | 80.4M | 188.81M |
| Investing | -2.76M | -40.03M | 8.77M | -43.87M | -200.53M |
| Financing | 84.55M | -6.25M | -13.7M | -7.86M | -11.07M |
| Market Cap | 2.45B |
| Price to Earnings Ratio | 39.38 |
| Price to Sales Ratio | 2.24 |
| Price to Cash Ratio | 25.11 |
| Price to Book Ratio | 4.41 |
| Dividend Yield | - |
| Shares Outstanding | 96.5M |
| Average Volume (1 week) | 1.1M |
| Average Volume (1 Month) | 1.04M |
| 52 Week Change | -34.37% |
| 52 Week High | 44.95 |
| 52 Week Low | 23.90 |
| Spread (Intraday) | 25.83 (51.02%) |
| Company Name | Progyny Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.progyny.com |
| Industry | misc health & allied svc,nec (8090) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
